Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Efficacy and Safety of K-924 in Hypercholesterolemia
NCT04289662Phase 3Completed
- Sponsor
- Kowa Company, Ltd.
- Start
- Mar 2020
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ezetimibe + pitavastatin in hypercholesterolemia, sponsored by Kowa Company, Ltd.. Started Mar 2020; status: completed.
02
Drugs
ezetimibe + pitavastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT04289662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04289662.